[Torsades de pointes ventricular tachycardia induced by intravenous amiodarone]
- PMID: 12647553
[Torsades de pointes ventricular tachycardia induced by intravenous amiodarone]
Abstract
The authors report on the case history of a 61 year old woman with hyperthyroidism induced atrial fibrillation, tachycardiomyopathy and congestive heart failure, in whom life threatening ventricular proarrhythmia (torsades de pointes) developed in response to intravenous amiodarone. The patient in a septic state was resuscitated because of ventricular fibrillation. The atrial fibrillation complicated by a high ventricular frequency was slowed down with intravenous amiodarone; additionally, the iodine-containing antiarrhythmic drug was expected to counter thyrotoxicosis. In response to amiodarone (2 x 300 mg), the sinus rhythm was restored, but the excessive post-cardioversion bradycardia led to the development of extreme QT interval prolongation and torsades de pointes ventricular tachycardias that often degenerated into ventricular fibrillation. In connection with this case, the authors survey those electropharmacological and pathophysiological factors which may have played a role in the emergence of ventricular proarrhythmia based on a lengthening of repolarization through the exhaustion of the repolarization reserve.
Similar articles
-
[Amiodarone-induced torsade de pointes--five case reports].Kardiol Pol. 2004 Apr;60(4):365-70; discussion 371. Kardiol Pol. 2004. PMID: 15226788 Polish.
-
"Torsade de pointes" during amiodarone infusion in a cirrhotic woman with a prolonged QT interval.Dig Liver Dis. 2009 Jul;41(7):535-8. doi: 10.1016/j.dld.2007.11.017. Epub 2008 Feb 21. Dig Liver Dis. 2009. PMID: 18294935
-
QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone.Pacing Clin Electrophysiol. 2005 May;28(5):472-3. doi: 10.1111/j.1540-8159.2005.09348.x. Pacing Clin Electrophysiol. 2005. PMID: 15869686
-
Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade.Can J Cardiol. 1997 Apr;13(4):383-6. Can J Cardiol. 1997. PMID: 9141970 Review.
-
Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.Pharmacotherapy. 2007 Sep;27(9):1297-305. doi: 10.1592/phco.27.9.1297. Pharmacotherapy. 2007. PMID: 17723083 Review.